Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Ruminococcin C, a promising antibiotic produced by a human gut symbiont.

Chiumento S, Roblin C, Kieffer-Jaquinod S, Tachon S, Leprètre C, Basset C, Aditiyarini D, Olleik H, Nicoletti C, Bornet O, Iranzo O, Maresca M, Hardré R, Fons M, Giardina T, Devillard E, Guerlesquin F, Couté Y, Atta M, Perrier J, Lafond M, Duarte V.

Sci Adv. 2019 Sep 25;5(9):eaaw9969. doi: 10.1126/sciadv.aaw9969. eCollection 2019 Sep.

2.

Deciphering the specific interaction between the acyl carrier protein IacP and the T3SS-major hydrophobic translocator SipB from Salmonella.

Canestrari MJ, Serrano B, Bartoli J, Prima V, Bornet O, Puppo R, Bouveret E, Guerlesquin F, Viala JP.

FEBS Lett. 2019 Sep 4. doi: 10.1002/1873-3468.13593. [Epub ahead of print]

PMID:
31486064
3.

Electrostatic interactions between the CTX phage minor coat protein and the bacterial host receptor TolA drive the pathogenic conversion of Vibrio cholerae.

Houot L, Navarro R, Nouailler M, Duché D, Guerlesquin F, Lloubes R.

J Biol Chem. 2018 May 11;293(19):7263. doi: 10.1074/jbc.AAC118.003402. No abstract available.

4.

Tryptophan-mediated Dimerization of the TssL Transmembrane Anchor Is Required for Type VI Secretion System Activity.

Zoued A, Duneau JP, Durand E, España AP, Journet L, Guerlesquin F, Cascales E.

J Mol Biol. 2018 Mar 30;430(7):987-1003. doi: 10.1016/j.jmb.2018.02.008. Epub 2018 Feb 17.

PMID:
29458124
5.

1H, 13C and 15N assignments of the C-terminal intrinsically disordered cytosolic fragment of the receptor tyrosine kinase ErbB2.

Wang Y, Pinet L, Assrir N, Elantak L, Guerlesquin F, Badache A, Lescop E, van Heijenoort C.

Biomol NMR Assign. 2018 Apr;12(1):23-26. doi: 10.1007/s12104-017-9773-4. Epub 2017 Sep 13.

6.

Structural and functional insights into the periplasmic detector domain of the GacS histidine kinase controlling biofilm formation in Pseudomonas aeruginosa.

Ali-Ahmad A, Fadel F, Sebban-Kreuzer C, Ba M, Pélissier GD, Bornet O, Guerlesquin F, Bourne Y, Bordi C, Vincent F.

Sci Rep. 2017 Sep 12;7(1):11262. doi: 10.1038/s41598-017-11361-3.

7.

Electrostatic interactions between the CTX phage minor coat protein and the bacterial host receptor TolA drive the pathogenic conversion of Vibrio cholerae.

Houot L, Navarro R, Nouailler M, Duché D, Guerlesquin F, Lloubes R.

J Biol Chem. 2017 Aug 18;292(33):13584-13598. doi: 10.1074/jbc.M117.786061. Epub 2017 Jun 22. Erratum in: J Biol Chem. 2018 May 11;293(19):7263.

8.

NMR assignments of the GacS histidine-kinase periplasmic detection domain from Pseudomonas aeruginosa PAO1.

Ali-Ahmad A, Bornet O, Fadel F, Bourne Y, Vincent F, Bordi C, Guerlesquin F, Sebban-Kreuzer C.

Biomol NMR Assign. 2017 Apr;11(1):25-28. doi: 10.1007/s12104-016-9714-7. Epub 2016 Oct 6.

PMID:
27714507
9.

(1)H, (15)N and (13)C resonance assignments of the C-terminal domain of Vibrio cholerae TolA protein.

Navarro R, Bornet O, Houot L, Lloubes R, Guerlesquin F, Nouailler M.

Biomol NMR Assign. 2016 Oct;10(2):311-3. doi: 10.1007/s12104-016-9690-y. Epub 2016 Jul 19.

PMID:
27436120
10.

Pre-B cell receptor binding to galectin-1 modifies galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactions.

Bonzi J, Bornet O, Betzi S, Kasper BT, Mahal LK, Mancini SJ, Schiff C, Sebban-Kreuzer C, Guerlesquin F, Elantak L.

Nat Commun. 2015 Feb 24;6:6194. doi: 10.1038/ncomms7194.

PMID:
25708191
11.

Glycan dependence of Galectin-3 self-association properties.

Halimi H, Rigato A, Byrne D, Ferracci G, Sebban-Kreuzer C, ElAntak L, Guerlesquin F.

PLoS One. 2014 Nov 4;9(11):e111836. doi: 10.1371/journal.pone.0111836. eCollection 2014.

12.

Structural and functional characterization of the Clostridium perfringens N-acetylmannosamine-6-phosphate 2-epimerase essential for the sialic acid salvage pathway.

Pélissier MC, Sebban-Kreuzer C, Guerlesquin F, Brannigan JA, Bourne Y, Vincent F.

J Biol Chem. 2014 Dec 19;289(51):35215-24. doi: 10.1074/jbc.M114.604272. Epub 2014 Oct 15.

13.

Examination of galectin-induced lattice formation on early B-cell development.

Mancini SJ, Elantak L, Boned A, Espéli M, Guerlesquin F, Schiff C.

Methods Mol Biol. 2015;1207:169-84. doi: 10.1007/978-1-4939-1396-1_11.

PMID:
25253140
14.

Identification of a Src kinase SH3 binding site in the C-terminal domain of the human ErbB2 receptor tyrosine kinase.

Bornet O, Nouailler M, Feracci M, Sebban-Kreuzer C, Byrne D, Halimi H, Morelli X, Badache A, Guerlesquin F.

FEBS Lett. 2014 Jun 5;588(12):2031-6. doi: 10.1016/j.febslet.2014.04.029. Epub 2014 May 8.

15.

¹H, ¹³C and ¹⁵N backbone and side-chain chemical shift assignments for reduced unusual thioredoxin Patrx2 of Pseudomonas aeruginosa.

Garcin EB, Bornet O, Elantak L, Nouailler M, Guerlesquin F, Sebban-Kreuzer C.

Biomol NMR Assign. 2014 Oct;8(2):247-50. doi: 10.1007/s12104-013-9493-3. Epub 2013 Jun 15.

PMID:
23771858
16.

Structural basis for galectin-1-dependent pre-B cell receptor (pre-BCR) activation.

Elantak L, Espeli M, Boned A, Bornet O, Bonzi J, Gauthier L, Feracci M, Roche P, Guerlesquin F, Schiff C.

J Biol Chem. 2012 Dec 28;287(53):44703-13. doi: 10.1074/jbc.M112.395152. Epub 2012 Nov 2.

17.

Structural and mechanistic insights into unusual thiol disulfide oxidoreductase.

Garcin EB, Bornet O, Elantak L, Vita N, Pieulle L, Guerlesquin F, Sebban-Kreuzer C.

J Biol Chem. 2012 Jan 13;287(3):1688-97. doi: 10.1074/jbc.M111.288316. Epub 2011 Nov 28.

18.

MEMO associated with an ErbB2 receptor phosphopeptide reveals a new phosphotyrosine motif.

Feracci M, Pimentel C, Bornet O, Roche P, Salaun D, Badache A, Guerlesquin F.

FEBS Lett. 2011 Sep 2;585(17):2688-92. doi: 10.1016/j.febslet.2011.07.048. Epub 2011 Aug 10.

19.

1H, 13C and 15N chemical shift assignments of the thioredoxin from the obligate anaerobe Desulfovibrio vulgaris Hildenborough.

Garcin EB, Bornet O, Pieulle L, Guerlesquin F, Sebban-Kreuzer C.

Biomol NMR Assign. 2011 Oct;5(2):177-9. doi: 10.1007/s12104-011-9294-5. Epub 2011 Feb 3.

PMID:
21287302
20.

1H, 13C and 15N backbone and side-chain chemical shift assignments for oxidized and reduced desulfothioredoxin.

Garcin EB, Bornet O, Pieulle L, Guerlesquin F, Sebban-Kreuzer C.

Biomol NMR Assign. 2010 Oct;4(2):135-7. doi: 10.1007/s12104-010-9226-9.

PMID:
20390383
21.

Basis of recognition between the NarJ chaperone and the N-terminus of the NarG subunit from Escherichia coli nitrate reductase.

Zakian S, Lafitte D, Vergnes A, Pimentel C, Sebban-Kreuzer C, Toci R, Claude JB, Guerlesquin F, Magalon A.

FEBS J. 2010 Apr;277(8):1886-95. doi: 10.1111/j.1742-4658.2010.07611.x. Epub 2010 Mar 2.

22.

Protein-protein interaction inhibition (2P2I): fewer and fewer undruggable targets.

Betzi S, Guerlesquin F, Morelli X.

Comb Chem High Throughput Screen. 2009 Dec;12(10):968-83. Review.

PMID:
20025563
23.

NMR and MD investigations of human galectin-1/oligosaccharide complexes.

Meynier C, Feracci M, Espeli M, Chaspoul F, Gallice P, Schiff C, Guerlesquin F, Roche P.

Biophys J. 2009 Dec 16;97(12):3168-77. doi: 10.1016/j.bpj.2009.09.026.

24.
25.

Characterisation of the electron transfer and complex formation between flavodoxin from D. vulgaris and the haem domain of cytochrome P450 BM3 from B. megaterium.

Fantuzzi A, Meharenna YT, Briscoe PB, Guerlesquin F, Sadeghi SJ, Gilardi G.

Biochim Biophys Acta. 2009 Apr;1787(4):234-41. doi: 10.1016/j.bbabio.2009.01.016. Epub 2009 Jan 30.

26.

TRF2 promotes, remodels and protects telomeric Holliday junctions.

Poulet A, Buisson R, Faivre-Moskalenko C, Koelblen M, Amiard S, Montel F, Cuesta-Lopez S, Bornet O, Guerlesquin F, Godet T, Moukhtar J, Argoul F, Déclais AC, Lilley DM, Ip SC, West SC, Gilson E, Giraud-Panis MJ.

EMBO J. 2009 Mar 18;28(6):641-51. doi: 10.1038/emboj.2009.11. Epub 2009 Feb 5.

27.

Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein.

Betzi S, Restouin A, Opi S, Arold ST, Parrot I, Guerlesquin F, Morelli X, Collette Y.

Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19256-61. Epub 2007 Nov 27.

28.

GFscore: a general nonlinear consensus scoring function for high-throughput docking.

Betzi S, Suhre K, Chétrit B, Guerlesquin F, Morelli X.

J Chem Inf Model. 2006 Jul-Aug;46(4):1704-12.

PMID:
16859302
29.

Solution structure of HndAc: a thioredoxin-like domain involved in the NADP-reducing hydrogenase complex.

Nouailler M, Morelli X, Bornet O, Chetrit B, Dermoun Z, Guerlesquin F.

Protein Sci. 2006 Jun;15(6):1369-78.

30.

Structural analysis of the HiPIP from the acidophilic bacteria: Acidithiobacillus ferrooxidans.

Nouailler M, Bruscella P, Lojou E, Lebrun R, Bonnefoy V, Guerlesquin F.

Extremophiles. 2006 Jun;10(3):191-8. Epub 2006 Apr 8.

PMID:
16604275
31.

Role of the tetrahemic subunit in Desulfovibrio vulgaris hildenborough formate dehydrogenase.

ElAntak L, Dolla A, Durand MC, Bianco P, Guerlesquin F.

Biochemistry. 2005 Nov 15;44(45):14828-34.

PMID:
16274230
32.

The type I/type II cytochrome c3 complex: an electron transfer link in the hydrogen-sulfate reduction pathway.

Pieulle L, Morelli X, Gallice P, Lojou E, Barbier P, Czjzek M, Bianco P, Guerlesquin F, Hatchikian EC.

J Mol Biol. 2005 Nov 18;354(1):73-90. Epub 2005 Sep 29.

PMID:
16226767
33.

Synechocystis ferredoxin/ferredoxin-NADP(+)-reductase/NADP+ complex: Structural model obtained by NMR-restrained docking.

Palma PN, Lagoutte B, Krippahl L, Moura JJ, Guerlesquin F.

FEBS Lett. 2005 Aug 29;579(21):4585-90.

34.

Structural and genetic analyses reveal a key role in prophage excision for the TorI response regulator inhibitor.

Elantak L, Ansaldi M, Guerlesquin F, Méjean V, Morelli X.

J Biol Chem. 2005 Nov 4;280(44):36802-8. Epub 2005 Aug 2.

35.

Solution structure of the E.coli TolA C-terminal domain reveals conformational changes upon binding to the phage g3p N-terminal domain.

Deprez C, Lloubès R, Gavioli M, Marion D, Guerlesquin F, Blanchard L.

J Mol Biol. 2005 Mar 4;346(4):1047-57. Epub 2005 Jan 12.

PMID:
15701516
36.

Multiple orientations in a physiological complex: the pyruvate-ferredoxin oxidoreductase-ferredoxin system.

Pieulle L, Nouailler M, Morelli X, Cavazza C, Gallice P, Blanchet S, Bianco P, Guerlesquin F, Hatchikian EC.

Biochemistry. 2004 Dec 14;43(49):15480-93.

PMID:
15581360
37.

A copper protein and a cytochrome bind at the same site on bacterial cytochrome c peroxidase.

Pauleta SR, Cooper A, Nutley M, Errington N, Harding S, Guerlesquin F, Goodhew CF, Moura I, Moura JJ, Pettigrew GW.

Biochemistry. 2004 Nov 23;43(46):14566-76.

PMID:
15544327
38.

Paracoccus pantotrophus pseudoazurin is an electron donor to cytochrome c peroxidase.

Pauleta SR, Guerlesquin F, Goodhew CF, Devreese B, Van Beeumen J, Pereira AS, Moura I, Pettigrew GW.

Biochemistry. 2004 Sep 7;43(35):11214-25.

PMID:
15366931
39.

The cytochrome c3-[Fe]-hydrogenase electron-transfer complex: structural model by NMR restrained docking.

ElAntak L, Morelli X, Bornet O, Hatchikian C, Czjzek M, Dolla A, Guerlesquin F.

FEBS Lett. 2003 Jul 31;548(1-3):1-4.

40.

The crystal structure of the hexadeca-heme cytochrome Hmc and a structural model of its complex with cytochrome c(3).

Czjzek M, ElAntak L, Zamboni V, Morelli X, Dolla A, Guerlesquin F, Bruschi M.

Structure. 2002 Dec;10(12):1677-86.

41.

The NADP-reducing hydrogenase from Desulfovibrio fructosovorans: functional interaction between the C-terminal region of HndA and the N-terminal region of HndD subunits.

Dermoun Z, De Luca G, Asso M, Bertrand P, Guerlesquin F, Guigliarelli B.

Biochim Biophys Acta. 2002 Dec 2;1556(2-3):217-25.

42.

Sequential NMR assignment of the ferri-cytochrome c3 from Desulfovibrio vulgaris Hildenborough.

Elantak L, Bornet O, Morelli X, Dolla A, Guerlesquin F.

J Biomol NMR. 2002 May;23(1):69-70. No abstract available.

PMID:
12061720
43.

Macromolecular import into Escherichia coli: the TolA C-terminal domain changes conformation when interacting with the colicin A toxin.

Deprez C, Blanchard L, Guerlesquin F, Gavioli M, Simorre JP, Lazdunski C, Marion D, Lloubès R.

Biochemistry. 2002 Feb 26;41(8):2589-98.

PMID:
11851406
44.

Cytochromes c555 from the hyperthermophilic bacterium Aquifex aeolicus. 2. Heterologous production of soluble cytochrome c555s and investigation of the role of methionine residues.

Aubert C, Guerlesquin F, Bianco P, Leroy G, Tron P, Stetter KO, Bruschi M.

Biochemistry. 2001 Nov 13;40(45):13690-8.

PMID:
11695918
45.

A novel approach for assessing macromolecular complexes combining soft-docking calculations with NMR data.

Morelli XJ, Palma PN, Guerlesquin F, Rigby AC.

Protein Sci. 2001 Oct;10(10):2131-7.

46.

Assignment of the 1H, 15N and 13C resonances of the C-terminal domain of the TolA protein of Escherichia coli, involved in cell envelope integrity.

Deprez C, Blanchard L, Simorre JP, Gavioli M, Guerlesquin F, Lazdunski C, Lloubès R, Marion D.

J Biomol NMR. 2000 Oct;18(2):179-80. No abstract available.

PMID:
11101224
47.

Interactions of bile salt micelles and colipase studied through intermolecular nOes.

Dominguez C, Sebban-Kreuzer C, Bornet O, Kerfelec B, Chapus C, Guerlesquin F.

FEBS Lett. 2000 Sep 29;482(1-2):109-12.

48.

Escherichia coli is able to produce heterologous tetraheme cytochrome c(3) when the ccm genes are co-expressed.

Herbaud ML, Aubert C, Durand MC, Guerlesquin F, Thöny-Meyer L, Dolla A.

Biochim Biophys Acta. 2000 Aug 31;1481(1):18-24.

PMID:
11004576
49.

Structural model of the Fe-hydrogenase/cytochrome c553 complex combining transverse relaxation-optimized spectroscopy experiments and soft docking calculations.

Morelli X, Czjzek M, Hatchikian CE, Bornet O, Fontecilla-Camps JC, Palma NP, Moura JJ, Guerlesquin F.

J Biol Chem. 2000 Jul 28;275(30):23204-10.

50.

Heteronuclear NMR and soft docking: an experimental approach for a structural model of the cytochrome c553-ferredoxin complex.

Morelli X, Dolla A, Czjzek M, Palma PN, Blasco F, Krippahl L, Moura JJ, Guerlesquin F.

Biochemistry. 2000 Mar 14;39(10):2530-7.

PMID:
10704202

Supplemental Content

Loading ...
Support Center